This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2003 Feb;58(2):96-7.

doi: 10.1136/thorax.58.2.96.

The new front line treatment for malignant pleural mesothelioma?

PMID: 12554885
PMCID: PMC1746576
DOI: 10.1136/thorax.58.2.96

Editorial

The new front line treatment for malignant pleural mesothelioma?

J P C Steele. Thorax. 2003 Feb.

. 2003 Feb;58(2):96-7.

doi: 10.1136/thorax.58.2.96.

Author

PMID: 12554885
PMCID: PMC1746576
DOI: 10.1136/thorax.58.2.96

No abstract available

PubMed Disclaimer

Similar articles

Standard therapy for the treatment of malignant pleural mesothelioma.
Vogelzang NJ. Vogelzang NJ. Lung Cancer. 2005 Oct;50 Suppl 1:S23-4. doi: 10.1016/s0169-5002(05)81557-0. Lung Cancer. 2005. PMID: 16291429
Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care?
Rusch VW. Rusch VW. J Clin Oncol. 2003 Jul 15;21(14):2629-30. doi: 10.1200/JCO.2003.02.043. J Clin Oncol. 2003. PMID: 12860935 No abstract available.
[Malignant pleural mesothelioma: further options].
van Hezik EJ. van Hezik EJ. Arch Bronconeumol. 2005 Dec;41(12):703. doi: 10.1016/s1579-2129(06)60339-x. Arch Bronconeumol. 2005. PMID: 16373048 Spanish. No abstract available.
Pemetrexed alone and in combination with platinum compounds in the management of malignant mesothelioma.
Suwanrusme H, Meyer ML, Green MR. Suwanrusme H, et al. Clin Lung Cancer. 2004 Apr;5 Suppl 2:S56-60. doi: 10.3816/clc.2004.s.004. Clin Lung Cancer. 2004. PMID: 15117426 Review.
Pemetrexed-cisplatin combination in mesothelioma.
Reck M, Gatzemeier U. Reck M, et al. Expert Rev Anticancer Ther. 2005 Apr;5(2):231-7. doi: 10.1586/14737140.5.2.231. Expert Rev Anticancer Ther. 2005. PMID: 15877521 Review.

See all similar articles

Cited by

Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma.
Goudar RK. Goudar RK. Ther Clin Risk Manag. 2008 Feb;4(1):205-11. doi: 10.2147/tcrm.s1603. Ther Clin Risk Manag. 2008. PMID: 18728709 Free PMC article.
Management options for malignant pleural mesothelioma: clinical and cost considerations.
Goudar RK. Goudar RK. Drugs. 2007;67(8):1149-65. doi: 10.2165/00003495-200767080-00005. Drugs. 2007. PMID: 17521217 Review.
BTS randomised feasibility study of active symptom control with or without chemotherapy in malignant pleural mesothelioma: ISRCTN 54469112.
Muers MF, Rudd RM, O'Brien ME, Qian W, Hodson A, Parmar MK, Girling DJ; British Thoracic Society Mesothelioma Group. Muers MF, et al. Thorax. 2004 Feb;59(2):144-8. doi: 10.1136/thorax.2003.009290. Thorax. 2004. PMID: 14760156 Free PMC article. Clinical Trial.
New therapeutic options for mesothelioma.
Goudar RK. Goudar RK. Curr Oncol Rep. 2005 Jul;7(4):260-5. doi: 10.1007/s11912-005-0048-3. Curr Oncol Rep. 2005. PMID: 15946584 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information